
    
      The primary objective of this study is to provide preliminary efficacy and safety data on the
      enteral administration of a one-time dose of tranexamic acid to critically ill patients for
      the reduction of morbidity at 28 days after enrollment in the study.

      Secondary objectives of this study are to determine the efficacy of administration of enteral
      tranexamic acid in reducing intensive care unit (ICU) and hospital length-of-stay, as well
      and mortality and morbidity at 6 months.
    
  